[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 2861 Introduced in Senate (IS)]

<DOC>






114th CONGRESS
  2d Session
                                S. 2861

 To require the Secretary of Defense to review and monitor prescribing 
practices at military treatment facilities of pharmaceutical agents for 
                the treatment of post-traumatic stress.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             April 27, 2016

  Mr. Rounds introduced the following bill; which was read twice and 
              referred to the Committee on Armed Services

_______________________________________________________________________

                                 A BILL


 
 To require the Secretary of Defense to review and monitor prescribing 
practices at military treatment facilities of pharmaceutical agents for 
                the treatment of post-traumatic stress.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Post-Traumatic Stress Disorder 
Medication Prescribing Improvement Act of 2016''.

SEC. 2. REQUIREMENT TO REVIEW AND MONITOR PRESCRIBING PRACTICES AT 
              MILITARY TREATMENT FACILITIES OF PHARMACEUTICAL AGENTS 
              FOR TREATMENT OF POST-TRAUMATIC STRESS.

    (a) In General.--Not later than 180 days after the date of the 
enactment of this Act, the Secretary of Defense shall--
            (1) conduct a comprehensive review of the prescribing 
        practices at military treatment facilities of pharmaceutical 
        agents for the treatment of post-traumatic stress;
            (2) implement a process or processes to monitor the 
        prescribing practices at military treatment facilities of 
        pharmaceutical agents that are discouraged from use under the 
        VA/DOD Clinical Practice Guideline for Management of Post-
        Traumatic Stress; and
            (3) implement a plan to address any deviations from such 
        guideline in prescribing practices of pharmaceutical agents for 
        management of post-traumatic stress at such facilities.
    (b) Pharmaceutical Agent Defined.--In this section, the term 
``pharmaceutical agent'' has the meaning given that term in section 
1074g(g) of title 10, United States Code.
                                 <all>
